Faron Pharmaceuticals

Turku, Southwest Finland, Finland, 20520

https://www.faron.com

Company profile

Faron Pharmaceuticals company profile

Faron is a clinical stage biopharmaceutical company developing novel treatments for medical conditions with significant unmet needs. The Company currently has a pipeline focusing on acute organ traumas, vascular damage and cancer immunotherapy.

Business identity

Website: https://www.faron.com
Contact email: [email protected]
Phone number: +35802469515
Operating status: Active
Company type: For Profit
Employee range: 11-50 employees
Revenue range: $0+
Founded: 2006-10-01, Month

LinkedIn X

Headquarters

Headquarters: Turku, Southwest Finland, Finland
Postal code: 20520
Country code: FI
Continent: Europe

Capital profile

Funding and company signals

Funding stage: IPO
Funding rounds: 12
Total equity funding: $36.9M
Last funding: Post IPO Debt / $16.6M / 2025-04-03
Last equity funding: Post IPO Equity / $12.5M
Investors: 7
Lead investors: 6
Founders: 1
Articles: 136
Exited on: 2015-11-17

Categories and groups

Biopharma Biotechnology Medical Pharmaceutical Biotechnology Health Care Science and Engineering

Founders and investors

Founders

Markku Jalkanen

Lead investors

Business FinlandEuropean Innovation CouncilHeights Capital ManagementIPF PartnersTimo SyrjäläU.S. Department of Defense

Investors

Blood Cancer United, Inc.Business FinlandEuropean Innovation CouncilHeights Capital ManagementU.S. Department of Defense